NEW SYNTHESIS OF 11-(1-PIPERAZINYL)- DIBENZO[b,f][1,4]THIAZEPINE, A CRUCIAL INTERMEDIATE IN QUETIAPINE PRODUCTION.

Łukasz S. Kaczmarek ,  Katarzyna Badowska-Rosłonek ,  Elżbieta U. Stolarczyk ,  Wiesław Szelejewski 

Pharmaceutical Research Institute (IF), Rydygiera 8, Warszawa 01-793, Poland

Abstract

Quetiapine is a novel antipsychotic drug, showing higher activity and fewer side effects than the classical antypsychotic agents. 11-(1-Piperazinyl)dibenzo[b,f][1,4]thiazepine is the crucial intermediate in the synthesis of quetiapine:


q_1.JPG

Our invention1 relates to the process of the preparation of this intermediate. In comparison with the classical industrial method2 ours offers several advantages, i.e.:

- reduction of operations number and time; - higher total yield (75% vs. 60%); - lower consumption of solvents; - reduction of waste material quantity;

All these advantages result in considerable reduction of manufacturing costs.

1 Ł. Kaczmarek, K. Badowska-Rosłonek, E. Stolarczyk, W. Szelejewski, " Process for preparation of 11-(1-piperazinyl)dibenzo[b,f][1,4]thiazepine, an intermediate in the synthesis of the antipsychotic drug Quetiapine.", PCT/EP2004/051520 (2004).

2 EP 0240228

Related papers
  1. The Concept of the Central Strategic Program - Innovative Medicines
  2. Zolmitriptan synthesis and in-process control by HPLC methods
  3. The cytotoxic activity of glycosides of indolo[2,3-b]quinoline derivatives.
  4. Disubstituted indolo[2,3-b]quinoline derivatives - the cytotoxic activity in vitro against various human tumor cell lines.
  5. Mono substituted 5H- and 6H-indolo[2,3-b]quinoline derivatives and their ability to overcome the barrier of drug resistance.
  6. Isolation, structural elucidation and characterization of impurities in latanoprost
  7. Development of HPLC and GC methods for analysis of Zolmitriptan of pharmaceutical purity
  8. Optimization of AR-3 synthesis
  9. Polimorphism of Active Pharmaceutical Ingredients
  10. CAN A QUEST FOR A NEW DRUG OF POLISH ORIGIN BE SUCCESSFUL?
  11. ROPINIROL - GENERIC DRUG FOR PARKINSON'S DISEASE
  12. CHARACTERIZATION OF ARIPIPRAZOLE SOLVATE WITH ETHANOL AND POLYMORPHIC FORMS PRODUCED DURING ITS HEATING
  13. HPLC SEPARATION AND DETERMINATION OF ZIPRASIDONE
  14. OPTIMIZATION OF THE CHROMATOGRAPHIC SEPARATION BY HPLC METHOD AND CONFIRMATION OF THE IDENTITY OF CHOSEN ESCITALOPRAM OXALATE INTERMEDIATE PRODUCTS
  15. SYNTHESIS OF GLIMEPIRIDE - CRYSTAL STRUCTURE ANALYSIS STEP BY STEP
  16. GC METHOD FOR QUANTITATIVE DETER- MINATION OF RESIDUAL 2-(2-CHLORO- ETOXY)ETHANOL (CEE) AND N-METHYL- 2-PYRROLIDINONE (NMP) IN PHARMACEU- TICAL ACTIVE SUBSTANCE
  17. APPLICATION OF GC/MS FOR IDENTYFICATION OF THE SIDEPRODUCTS IN A PROCESS OF PREPARATION OF PRAMIPEXOLE.
  18. THE CYTOTOXIC GLYCOSIDES OF INDOLO[2,3-B]QUINOLINE DERIVATIVES. IN VITRO AND IN VIVO STUDIES
  19. MONO SUBSTITUTED 5H-INDOLO[2,3-B]- QUINOLINE DERIVATIVES AND THEIR ABILITY TO OVERCOME THE BARRIER OF DRUG RESISTANCE.
  20. DISUBSTITUTED INDOLO[2,3-b]QUINOLINE DERIVATIVES. THE CYTOTOXIC ACTIVITY IN VITRO AGAINST VARIOUS HUMAN TUMOR CELL LINE.
  21. SYNTHESIS OF PIOGLITAZONE HYDROCHLORIDE OF PHARMACEUTICAL PURITY AT SMALL PLANT SCALE
  22. NEW IMPROVED METHOD OF POLYMORPHIC α FORM OF IMATINIB MESYLATE (GLEEVEC®) SYNTHESIS.
  23. 1H AND 13C NMR DATA FOR INDOLO[2,3-b]QUINOLINES - AMINOGLYCOSIDE HYBRIDS, A NOVEL POTENT ANTICANCER DRUG FAMILY .

Presentation: Poster at V Multidyscyplinarna Konferencja Nauki o Leku, by Łukasz S. Kaczmarek
See On-line Journal of V Multidyscyplinarna Konferencja Nauki o Leku

Submitted: 2006-01-25 18:37
Revised:   2006-04-29 18:27
Google
 
Web science24.com
© 1998-2009 pielaszek research, all rights reserved Powered by the Conference Engine